Parathyroid hormone control and bone density in kidney disease
Part of Bones, joints & muscles, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older
- You have advanced chronic kidney disease (stage 4-5) and are not on dialysis
- Your parathyroid hormone (PTH) level is above normal, or you take medicine like Alphacalcidol or Cinacalcet to control it
- You have not had a kidney transplant
- You are not currently taking denosumab or bisphosphonates for osteoporosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests teriparatide (a hormone-like bone medicine) to improve bone health in people with advanced chronic kidney disease who are at risk for weak, low-turnover bone. It may help by changing how quickly your bones break down and rebuild.
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
This study checks how kidney disease affects bone health by measuring hormones like PTH and related blood markers. It may help doctors better diagnose bone problems that can occur with poor kidney function.
This trial looks at whether removing overactive parathyroid glands (parathyroidectomy) can help people who still have high calcium or low phosphate levels more than 6 months after a kidney transplant. If you have stable kidney function and meet certain blood test results, you may be able to join.
This trial looks at a personalized approach to diagnosing and treating bone problems caused by long-term kidney disease. It may help by matching treatment plans to the type of bone turnover found in your tests or biopsy.
This study looks at how eating different amounts of phosphorus affects your bones and blood calcium and phosphorus. It may help find better dietary recommendations for people with moderate chronic kidney disease.
Hear when a new Chronic Kidney Disease Mineral and Bone Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.